Julie Rubinstein sold $929K of ADPT stock

Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares of ADPT stock worth $929K, per an SEC Form 4 filed Nov 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 30, 2026, 5 days before it was made public.

ADPT has moved +5.0% since the trade date, from $26.64 to $27.98 (Nov 6, 2026 close).